Douglas Lane & Associates’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,200
Closed -$52.7K 229
2022
Q4
$52.7K Buy
+12,200
New +$52.7K ﹤0.01% 224